Related Experiment Video
Updated: Jan 18, 2026

05:55
Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
Published on: December 1, 2023
1.3K
Authors' Response to "Comment on 'SMPDL3B as a novel biomarker and therapeutic target in myalgic encephalomyelitis'"
Bita Rostami-Afshari1,2,3,4, Wesam Elremaly1,3,4, Anita Franco1,3,4
1Viscogliosi Laboratory in Molecular Genetics of Musculoskeletal Diseases, Azrieli Research Center, CHU Sainte-Justine, Montreal, QC, Canada.
Journal of Translational Medicine
|January 16, 2026
Abstract
No abstract available in PubMed .

